摘要
目的探讨肝动脉化疗栓塞术治疗原发性肝癌的疗效分析。方法选取2017年8月~2018年12月本院收治的原发性肝癌患者70例,依据随机数字表法分为A组和B组,每组35例,A组给予肝动脉化疗栓塞术治疗,B组给予化疗灌注术治疗,分析比较两组的治疗疗效。结果两组的总缓解率、复发率基本相同,差异无统计学意义(P>0.05),A组和B组不良反应比较,差异无统计学意义(P>0.05);随访24个月期间,A组生存率明显高于B组,差异有统计学意义(P<0.05)。结论肝动脉化疗栓塞术有利于提高患者的生存率,且具有良好的安全性,值得临床作进一步推广。
Objective To explore the curative effect of transcatheter arterial chemoembolization in treatment of primary liver cancer.Methods 70 patients with primary liver cancer who were admitted and treated in our hospital from August 2017 to December 2018 were selected.According to the random number table method,they were divided into group A and group B,with 35 cases in each group.Group A was treated with hepatic arterial chemoembolization while group B was treated with chemotherapy perfusion.The curative effects of the two groups were analyzed and compared.Results The total remission rate and recurrence rate of the two groups were basically the same,and there was no statistically significant difference(P>0.05).Adverse reactions in group A and group B were basically the same,and there was no statistically significant difference(P>0.05).During 24 months of follow-up,the survival rate of group A was significantly higher than that of group B,and the difference was statistically significant(P<0.05).Conclusion Hepatic arterial chemoembolization can improve the survival rate of patients and it has good safety.It is worthy of further clinical promotion.
作者
蔡宗洋
马洺远
林纲毅
CAI Zongyang;MA Mingyuan;LIN Gangyi(Department of Vascular Intervention,Shantou Central Hospital,Shantou 515000,China)
出处
《中国医药科学》
2020年第2期213-215,共3页
China Medicine And Pharmacy
关键词
肝动脉化疗栓塞术
原发性肝癌
化疗灌注术
总缓解率
Hepatic arterial chemoembolization
Primary liver cancer
Chemotherapy perfusion
Total remission rate
